Free press releases distribution network?

Agency / Source: DN Venture Partners

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems - Siam Life Science Ltd (SLS) secures exclusive License for unique Liver Cell Line from Premier U.S. Research Organization, Walter Reed Army Institute of Research (WRI) - Siam-Lifescience.com
Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems

 

PRZOOM - /newswire/ - Bangkok, Thailand, 2008/05/21 - Siam Life Science Ltd (SLS) secures exclusive License for unique Liver Cell Line from Premier U.S. Research Organization, Walter Reed Army Institute of Research (WRI) - Siam-Lifescience.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A breakthrough technology in the form of a unique, functional human liver cell line has the potential to become the new worldwide gold standard for preclinical drug evaluation studies. The cell line, licensed by Thailand-based human cell technology company, Siam Life Science Ltd. (SLS), was developed in Thailand at the Armed Forces Research Institute of the Medical Sciences (AFRIMS). The AFRIMS is a foreign activity of the Walter Reed Army Institute of Research (WRAIR) which is the largest and most diverse biomedical research laboratory in the United States’ Department of Defense.

Developed under a Cooperative Research and Development Agreement (CRADA), this unique human liver cell line is licensed to SLS on a worldwide basis and includes the exclusive right for SLS to sublicense the technology for certain uses to external partners. Known as HC-04, it is an immortalized cell line that can continue to grow and divide indefinitely in vitro. Unlike other immortalized liver cell lines, HC-04 was developed from normal human liver tissue without genetically manipulating the liver cells. More importantly, HC-04 has been shown to retain most of its normal liver cell functions and is therefore ideally suited for preclinical drug evaluation and drug safety studies. SLS was granted exclusive rights to these uses under the license with the Army.

The HC-04 cell line can be used for research and drug development for treating Malaria and Hepatitis. Use of HC-04 in malaria drug development is especially attractive because the cell line can support the in vitro development of two major Malaria parasites, Plasmodium falciparum and Plasmodium vivax. HC-04 cells may also be used in the development of bio-artificial liver devices and SLS was granted license rights to these uses as well.

SLS intends to make the HC-04 cell line available to the global pharmaceutical industry for toxicological and pharmacological testing as well as drug development. “There is a worldwide shortage of functional human liver cell test systems for preclinical drug evaluation studies,” said Walter Beerheide, PhD, CEO of SLS. “Most human liver cell lines currently on the market are not suitable for such studies, because they lose much of their normal liver cell characteristics. Our cell line addresses this and provides a reliable, stable and reproducible model for drug toxicology studies. It has the potential to become a gold standard among pharmacological and toxicological test systems for the pharma and life science industry. This latest development will contribute towards our goal of becoming an internationally-competitive human cell technology company.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: DN Venture Partners

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Walter Reed Army Institute of Research and Siam Life Science Ltd Develop New Gold Standard for Pharmacological and Toxicological Test Systems

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Marvin Ng - DN-Venture.com 
+65 9684 2133 pr[.]siam-lifescience.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any DN Venture Partners securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From DN Venture Partners / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today